KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

Nat Commun · 2025-Jul-21 · PMID 40691143

Panel G提取完成待 EXE 对齐验证

overall survival

Fig. 1. Interrogating response heterogeneity via blinded multi-omic analysis of R- versus NR-mesotheliomas. A Upper panel. Kaplan-Meier curve showing investigator-reported progression-free survival for nivolumab and placebo treatment groups in CONFIRM. Lower panel. Kaplan-Meier curve showing overall survival (proportion alive) for nivolumab and placebo treatment groups in CONFIRM. B Chest computerised tomography scan of the chest of a patient who exhibited an extreme response to nivolumab over the course of 6 months. C Archival formalin fixed tumour blocks corresponding to patients who received nivolumab and had either a partial response (R) or progressive disease (no response, NR) as their best outcome, were subjected to next generation sequencing of the whole exome or transcriptome. These tissues were also spatially phenotyped using multiplex-immunofluorescence microscopy. Created in BioRender. Fennell, D. ( https://BioRender.com/sq9aqpm .) D Waterfall plot showing the selection of patients from R- vs NR-groups for blinded multi-omic analysis. E Spider plot showing the relative change from baseline for mesotheliomas in the NR- vs R-subgroups. F Kaplan-Meier plots for investigator reported PFS in the translational research cohorts denoted responder and non-responder respectively. These curves are descriptive only and are not formally comparable. G Kaplan-Meier plot for OS in the translational research cohorts denoted responder and non-responder respectively. These curves are descriptive only and are not formally comparable.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-0.27 – 1.26

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 33 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00001.00001.03922559
120.03901.00001.03923159
130.04551.00001.03923259
140.05191.00001.03923359
150.05841.00001.03923459
160.06490.97101.00763561
170.07140.97101.00763661
180.07790.92750.96033764
190.08440.91300.94453865
1100.09090.91300.94453965
1110.09740.91300.94454065
1120.10390.91300.94454165
1130.11040.91300.94454265
1140.11690.91300.94454365
1150.12340.91300.94454465
1160.12990.91300.94454565
1170.13640.91300.94454665
1180.14290.91300.94454765
1190.14940.91300.94454865
1200.15580.91300.94454965
1210.16230.91300.94455065
210.00000.88410.91302567
220.04550.88410.91303267
230.05190.97101.00763361
240.30520.73910.75537277
250.31170.73910.75537377
260.72730.66670.676413782
270.73380.66670.676413882
280.74030.66670.676413982
290.74680.66670.676414082
2100.75320.66670.676414182
2110.75970.66670.676414282
2120.76620.66670.676414382
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T17:31:30+00:00